Operations Management

Realizing ROI on Data Governance and Analytics in Healthcare; Data Governance in Healthcare, Part 3

This three-part blog series will explore what makes an organization high-performing in its use of data and analytics. Data governance in healthcare requires three components, starting with effective internal data governance structures that encourage executive buy-in and sponsorship, collecting the right data, and measuring the return on data and analytics investment.

HFMA May 17, 2022

In the pandemic’s latest phase, strategic issues for healthcare providers include labor, inflation and value-based payment

The struggles of smaller providers amid the COVID-19 pandemic are likely to give way to increased merger-and-acquisition activity in 2022, according to Wall Street analysts.

Nick Hut May 12, 2022

IPPS FY23 proposed rule: Tweaks are in store for Medicare’s quality-reporting and pay-for-performance programs

Temporary modifications to two pay-for-performance programs would ensure hospitals don’t face penalties amid the COVID-19 pandemic.

Nick Hut May 5, 2022

Latest financial metrics for hospitals show reasons for optimism but also persistent challenges

Hospital financial performance partially recovered in March as patient volumes returned to something closer to normal after a significant downturn during the omicron wave.

Nick Hut May 4, 2022

The negative effect of fat bias on health outcomes

Cardiologist and epidemiologist Dr. Christopher Labos discusses weight bias in healthcare, including what health indicators to focus on instead of weight and how to help patients who are at risk improve their health outcomes without explicit or implicit fat shaming.

Erika Grotto May 3, 2022

M&A update: A quiet quarter for hospital deal-making reflects the ongoing consequences of the pandemic

Merger-and-acquisition activity among hospitals and health systems remained well under pre-pandemic levels in Q1 2022.

Nick Hut April 27, 2022

Steve LeFar talks about the implications of care deferrals due to COVID-19

The economic and social impacts from deferred healthcare due to COVID-19 were already a major concern in the pandemic’s first year, portending severe declines in health status for Americans who stopped seeking care for fear of exposure to the coronavirus. In this Q&A, Strata Decision Technology’s Steve Lefar shares insights based on extensive data that tell the story of deferred care across the nation, and the likelihood that providers will see a rising tide of severely ill patients.

Eric C. Reese, PhD April 27, 2022

IPPS FY23 proposed rule: CMS seeks to bolster maternal health through a new public-facing hospital designation

Hospitals could attain the “Birthing Friendly” designation by attesting to having implemented best practices in maternal health.

Nick Hut April 26, 2022

Paul Keckley: Inflation’s impact on healthcare: 5 takeaways

For healthcare finance professionals, healthcare inflation requires intensified efforts to address five concerns: increased bad debt, increased operating costs, heightened public scrutiny of pricing policies and executive compensation, increased competition by privately funded competitors offering low-cost solutions and growth of “Occupy Healthcare” movements.

Paul H. Keckley, PhD April 26, 2022

Cost Effectiveness of Health Report, April 2022

The April 2022 edition of HFMA’s Cost Effectiveness of Health Report includes a preview the May issue of hfm, which focuses on telehealth, a key tool for promoting value-based care CEoH. Another article explores ways to promote health equity in revenue cycle processes, and a case study describes how one health system embarked on an initiative to achieve greater diversity among its revenue cycle staff.

HFMA April 26, 2022
googletag.cmd.push( function () { googletag.display( 'hfma-gpt-leaderboard' ); } );